Cold Form Blister Packaging

Cold Form Blister Packaging

Global Cold Form Blister Packaging Market to Reach US$1.6 Billion by 2030

The global market for Cold Form Blister Packaging estimated at US$1.1 Billion in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Aluminum-based Cold Form Blister Packaging, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$831.8 Million by the end of the analysis period. Growth in the Polyvinyl Chloride-based Cold Form Blister Packaging segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$144.7 Million While China is Forecast to Grow at 7.8% CAGR

The Cold Form Blister Packaging market in the U.S. is estimated at US$144.7 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$335.8 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Cold Form Blister Packaging Market - Key Trends & Drivers Summarized

Cold form blister packaging is a pivotal innovation in the pharmaceutical and consumer goods industries, providing robust protection for products against environmental factors such as moisture, oxygen, and light. This packaging technique involves forming the blister cavities using a laminate of aluminum, polyamide (nylon), and PVC (polyvinyl chloride) films without applying heat, which ensures the stability of temperature-sensitive medications. The aluminum layer acts as an impermeable barrier, safeguarding the contents from external elements and extending the product`s shelf life. This method is particularly favored for packaging pharmaceuticals, as it offers superior protection for tablets, capsules, and other sensitive products, ensuring they remain effective until consumption.

The production process of cold form blister packaging involves the use of sophisticated machinery that precisely shapes the laminate into blister cavities. Unlike thermoforming, which uses heat to mold the plastic, cold forming maintains the integrity of the films, making it suitable for packaging sensitive products. This process, however, is more complex and slower than thermoforming, leading to higher production costs. Despite this, the benefits in terms of product protection and longevity justify the investment, especially in the pharmaceutical industry. Additionally, the visual appeal and tamper-evident features of cold form blister packaging make it a preferred choice for high-value items and ensure consumer confidence in the product`s authenticity and safety.

The growth in the cold form blister packaging market is driven by several factors, including advancements in packaging technology, increased demand for pharmaceutical products, and changing consumer behavior towards product safety and sustainability. Technological innovations have led to the development of more efficient and precise cold forming machines, reducing production time and costs. The global rise in chronic diseases and the aging population have escalated the demand for pharmaceuticals, subsequently boosting the need for effective packaging solutions. Consumers are increasingly prioritizing product safety and integrity, driving manufacturers to adopt packaging that offers superior protection. Additionally, the trend towards sustainable packaging materials has influenced the market, with companies exploring eco-friendly alternatives to traditional plastics used in blister packs. Regulatory requirements for pharmaceutical packaging also play a crucial role, as stringent standards necessitate the use of packaging that ensures the highest level of product protection, further propelling the adoption of cold form blister packaging.

Select Competitors (Total 32 Featured) -

• Sonoco Products Company
• Tekni-Plex, Inc.
• Winpak Ltd.
• UFLEX Ltd.
• Constantia Flexibles International GmbH
• Ropack Pharma Solutions
• Essentra PLC
• Aphena Pharma Solutions, Inc.
• PAXXUS, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.